Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Published in: Journal of Infection and Chemotherapy 4/2006

01-08-2006 | ORIGINAL ARTICLE

Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates

Authors: Yoshihiro Kobashi, Kouichiro Yoshida, Naoyuki Miyashita, Yoshihito Niki, Mikio Oka

Published in: Journal of Infection and Chemotherapy | Issue 4/2006

Login to get access
Metadata
Title
Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates
Authors
Yoshihiro Kobashi
Kouichiro Yoshida
Naoyuki Miyashita
Yoshihito Niki
Mikio Oka
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
Journal of Infection and Chemotherapy / Issue 4/2006
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-006-0457-8

Other articles of this Issue 4/2006

Journal of Infection and Chemotherapy 4/2006 Go to the issue

NOTE

Vapor activity of 72 essential oils against a Trichophyton mentagrophytes

ORIGINAL ARTICLE

In vitro synergistic effects of double combinations of β-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae

ORIGINAL ARTICLE

Impact of ceftazidime restriction on gram-negative bacterial resistance in an intensive care unit

REVIEW ARTICLE

Potential benefits and limitations of various strategies to mitigate the impact of an influenza pandemic

ORIGINAL ARTICLE

Nosocomial infection of β-lactam antibiotic-induced vancomycin-resistant Staphylococcus aureus (BIVR)

ORIGINAL ARTICLE

Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits